Development and Validation of a Multiplex Real-Time RT-PCR Assay for Simultaneous Detection of Avian Influenza Virus H5, H7, and H9 Subtypes in Poultry Respiratory Samples

Introduction

Avian influenza virus (AIV) is a negative-sense, single-stranded RNA virus belonging to the family Orthomyxoviridae. The virus is classified into subtypes based on the antigenic properties of its two surface glycoproteins: hemagglutinin (HA) and neuraminidase (NA). Among the 16 HA subtypes recognized in avian hosts, the H5, H7, and H9 subtypes are of particular veterinary and economic significance due to their potential to cause highly pathogenic avian influenza (HPAI) or their widespread circulation in poultry populations [1, 2]. Rapid and accurate detection of these subtypes is critical for implementing control measures, managing outbreaks, and supporting surveillance programs.

Traditional diagnostic methods for AIV include virus isolation in embryonated chicken eggs and serological assays such as the hemagglutination inhibition test. However, these methods are time-consuming, require specialized biocontainment facilities, and lack the throughput necessary for large-scale surveillance. Molecular diagnostic techniques, particularly real-time reverse transcription polymerase chain reaction (real-time RT-PCR), have become the cornerstone of AIV detection due to their high sensitivity, specificity, and rapid turnaround time. Singleplex real-time RT-PCR assays targeting the matrix (M) gene are widely used for generic AIV detection, but they cannot differentiate between subtypes. Subtype-specific identification requires targeting the HA gene, which is subject to greater genetic variation.

The development of a multiplex real-time RT-PCR assay capable of simultaneously detecting and differentiating H5, H7, and H9 subtypes from a single respiratory sample offers significant advantages in diagnostic efficiency, cost reduction, and sample conservation. This article provides a detailed technical review of the design, optimization, analytical validation, and field application of such an assay, following the principles established for other multiplex respiratory pathogen panels (e.g., Multiplex Real-Time RT-PCR for Simultaneous Detection of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Porcine Circovirus Type 2 (PCV2), and Swine Influenza A Virus (SIV) in Oral Fluids: Assay Design and Field Validation).

Assay Design: Primer and Probe Selection

Target Gene Selection

The hemagglutinin (HA) gene is the primary target for subtype-specific detection of AIV. The HA gene encodes the receptor-binding protein responsible for viral attachment to host sialic acid receptors. The HA0 precursor protein is cleaved into HA1 and HA2 subunits by host proteases, a process essential for viral infectivity. The HA1 subunit contains the receptor-binding domain (RBD) and is the site of greatest genetic diversity among subtypes, whereas the HA2 stalk region is more conserved. For multiplex assay design, primer and probe sets must target conserved regions within the HA gene of each subtype while avoiding cross-reactivity with other subtypes or other avian respiratory viruses.

For H5, primer and probe sequences are typically designed to target a conserved region within the HA1 domain. For H7, the target region is often located in the HA2 domain or the cleavage site region, which contains a multibasic amino acid motif in HPAI strains. For H9, the target region is usually within the HA1 domain, which is relatively conserved among the H9 lineage circulating in Asian and Middle Eastern poultry populations. The selection of these regions requires comprehensive analysis of publicly available HA gene sequences to ensure coverage of circulating genetic lineages [1, 2].

Oligonucleotide Design Parameters

Multiplex assay design imposes additional constraints relative to singleplex assays. Primers and probes must have compatible melting temperatures (Tm) typically within a range of 58-62 degrees Celsius for primers and 68-70 degrees Celsius for probes. Amplicon length is kept short, generally between 70 and 150 base pairs, to maximize amplification efficiency and minimize competition among targets. Probe fluorophores are selected to have non-overlapping emission spectra for differentiation on a multichannel real-time PCR instrument. Common fluorophore combinations include FAM for one subtype, HEX or VIC for a second, and Cy5 for a third. Quenchers are typically non-fluorescent (e.g., BHQ-1, BHQ-2, or Iowa Black) to reduce background fluorescence.

Internal Control

A multiplex assay must include an internal positive control (IPC) to monitor for nucleic acid extraction efficiency, reverse transcription, and PCR inhibition. The IPC is often an exogenous RNA transcript (e.g., from a synthetic construct or an unrelated virus such as the MS2 bacteriophage) or an endogenous housekeeping gene (e.g., avian beta-actin or glyceraldehyde-3-phosphate dehydrogenase). The IPC is amplified using a separate primer-probe set labeled with a distinct fluorophore (e.g., ROX or Cy5.5). The inclusion of an IPC is essential for interpreting negative results, as a failed IPC indicates sample inhibition or extraction failure rather than a true negative result.

Assay Optimization

Primer and Probe Concentration Titration

Multiplex PCR reactions require optimization of primer and probe concentrations for each target to balance amplification efficiency and avoid preferential amplification of one target over others. Initial concentrations are typically 200-400 nM for each primer and 100-200 nM for each probe. These concentrations are then systematically varied in a checkerboard titration using synthetic RNA templates or in vitro transcribed RNA representing each subtype. The optimal concentration for each primer-probe set is the one that yields the lowest quantification cycle (Cq) value and highest endpoint fluorescence for its respective target without significantly increasing Cq values for the other targets.

Annealing Temperature Optimization

The annealing temperature is a critical parameter for multiplex PCR. A gradient PCR is performed to determine the optimal annealing temperature that allows efficient and specific amplification of all three targets simultaneously. Typically, a two-step thermal cycling protocol (annealing and extension at the same temperature) is used for real-time RT-PCR. The optimal temperature is often in the range of 55-60 degrees Celsius for assays using standard Taq polymerase. For assays using a hot-start polymerase, a higher annealing temperature (60-64 degrees Celsius) is often feasible, improving specificity by reducing non-specific primer binding.

Reverse Transcription Conditions

The reverse transcription step must be compatible with the multiplex PCR chemistry. Random hexamers or subtype-specific reverse primers are used to generate cDNA. The inclusion of a reverse transcriptase enzyme with high thermal stability (e.g., a thermostable group II intron reverse transcriptase or a modified M-MLV reverse transcriptase) improves cDNA yield, particularly for RNA templates with secondary structure. The RT step is typically performed at 45-50 degrees Celsius for 10-15 minutes, followed by enzyme inactivation at 95 degrees Celsius for 2-5 minutes.

Master Mix Composition

Commercially available one-step real-time RT-PCR master mixes are preferred for their optimized buffer composition, dNTP concentrations, and enzyme blends. The buffer composition must support the activity of both the reverse transcriptase and the DNA polymerase. Magnesium chloride concentration is typically 3-5 mM. The addition of a PCR enhancer such as betaine or DMSO (at 1-3% v/v) may improve amplification of GC-rich regions, particularly within the HA gene. The final reaction volume is typically 20-25 microliters, with 2-5 microliters of RNA template added per reaction.

Analytical Sensitivity: Limit of Detection

The limit of detection (LOD) is the lowest concentration of target RNA that can be reliably detected with a predefined probability, typically 95%. The LOD is determined by testing serial dilutions of quantified in vitro transcribed RNA or purified viral RNA from cultured virus. Each dilution is tested in multiple replicates (e.g., 20 replicates for each of 5-8 dilution levels), and the detection rate is calculated. The LOD is then estimated using probit regression analysis.

For a multiplex assay targeting H5, H7, and H9, the LOD for each target is expected to be in the range of 10-50 RNA copies per reaction, which is comparable to singleplex real-time RT-PCR assays. The presence of multiple primer-probe sets in a single reaction can cause competitive interference, potentially increasing the LOD for one or more targets. Careful optimization of primer and probe concentrations is required to minimize this interference. The LOD for the IPC must also be determined to ensure that it does not compete with the diagnostic targets for reagents.

Analytical Specificity: Cross-Reactivity Testing

Analytical specificity is assessed by testing the assay against a panel of closely related and un-related avian respiratory pathogens. The panel should include:

• Other AIV subtypes (e.g., H1, H3, H4, H6, H8, H10, H11) to confirm subtype specificity.
• Newcastle disease virus (NDV, Avian paramyxovirus serotype 1), a common differential diagnosis for respiratory disease in poultry.
• Infectious bronchitis virus (IBV, a coronavirus).
• Avian metapneumovirus (aMPV).
• Avian reovirus.
• Infectious laryngotracheitis virus (ILTV, a herpesvirus).
• Bacterial pathogens such as Mycoplasma gallisepticum and Pasteurella multocida.

No cross-reactivity should be observed for any of these non-target pathogens. The assay must specifically amplify only the intended H5, H7, and H9 targets. Testing of a panel of uninfected poultry respiratory swabs is also performed to confirm that the assay does not generate false-positive signals due to non-specific amplification of host nucleic acids or environmental contaminants.

Validation Using Field Samples

Sample Collection and Processing

Field validation is performed using respiratory samples (tracheal swabs, oropharyngeal swabs, or lung tissue homogenates) collected from poultry flocks with suspected AIV infection. Samples are collected according to standard veterinary protocols and transported in viral transport medium (e.g., phosphate-buffered saline with antibiotics and 10% glycerol) at 4 degrees Celsius. RNA is extracted using a standard column-based or magnetic bead-based nucleic acid extraction method.

Comparative Testing

The performance of the multiplex assay is evaluated by comparing its results to those of a reference standard, typically a combination of singleplex real-time RT-PCR assays for H5, H7, and H9 and virus isolation. The diagnostic sensitivity is calculated as the proportion of true positive samples (by the reference standard) that test positive by the multiplex assay. The diagnostic specificity is the proportion of true negative samples that test negative by the multiplex assay. The positive predictive value (PPV) and negative predictive value (NPV) are also calculated, taking into account the prevalence of infection in the tested population.

Agreement Analysis

The level of agreement between the multiplex assay and the reference standard is assessed using Cohen's kappa coefficient. A kappa value greater than 0.80 indicates excellent agreement. For discrepant results, additional testing (e.g., sequencing of the HA gene) is performed to resolve the true infection status.

Workflow Diagram

The following Mermaid diagram illustrates the workflow for the described multiplex real-time RT-PCR assay.

flowchart TD
    A[Sample Collection: Tracheal/Oropharyngeal Swabs in VTM], > B[Nucleic Acid Extraction: Column or Bead-Based]
    B, > C{RNA Quality Check: Spectrophotometry or Fluorometry}
    C, Pass, > D[Mix Preparation: Master Mix + Primers/Probes for H5, H7, H9, IPC]
    C, Fail, > E[Re-collect Sample]
    D, > F[Add RNA Template: 2-5 uL per Reaction]
    F, > G[Real-Time RT-PCR: 45-50C RT; 95C Denature; 55-60C Anneal/Extend x 40-45 Cycles]
    G, > H{Data Analysis: Cq and Endpoint Fluorescence}
    H, Positive for H5, H7, or H9, > I[Report Subtype: H5, H7, or H9 Positive]
    H, Negative for H5, H7, H9, IPC Positive, > J[Report: AIV Negative]
    H, Negative for H5, H7, H9, IPC Negative, > K[Report: Invalid – Re-extract and Retest]
    I, > L[Optional: Confirmatory Sequencing or HA Cleavage Site Analysis]
    J, > M[Result for Clinical Action/Surveillance]
    K, > B

Interpretation of Results

Interpretation criteria for a typical multiplex real-time RT-PCR assay are summarized in the table below.

| Target (Fluorophore) | Cq Value | IPC (Fluorophore) Cq Value | Interpretation | | :-, | :-, | :-, | :-, | | H5 (FAM), H7 (HEX), or H9 (Cy5) | < 38 | Valid (e.g., < 35) | Positive for respective subtype | | All diagnostic targets | No Cq | Valid | Negative for H5, H7, H9 | | All diagnostic targets | No Cq | No Cq or > 38 | Invalid (Inhibition or extraction failure); Re-test | | H5, H7, or H9 | < 38 | No Cq or > 38 | Positive; Report as positive regardless of IPC failure |

Quality Control

Each assay run must include the following controls:

• Positive Template Control (PTC): A synthetic RNA transcript or inactivated virus containing target sequences for H5, H7, and H9.
• Negative Template Control (NTC): Nuclease-free water added instead of RNA template.
• Negative Extraction Control (NEC): Nuclease-free water processed through the entire nucleic acid extraction procedure.
• Internal Positive Control (IPC): Added to each sample and control to monitor for inhibition.

The PTC must produce positive signals for all three targets. The NTC and NEC must produce no signal for any diagnostic target (Cq = 0 or > 40).

Discussion

The development and validation of a multiplex real-time RT-PCR assay for simultaneous detection of H5, H7, and H9 subtypes addresses a critical need in poultry diagnostics. The assay's ability to differentiate these three epidemiologically important subtypes in a single reaction reduces the time to result, conserves sample material, and lowers per-sample reagent costs compared to running three separate singleplex reactions. This is particularly advantageous for surveillance programs where large numbers of samples must be processed rapidly [1, 2].

The use of the HA gene as the target ensures subtype specificity, which is essential for informing control measures. For example, detection of H5 or H7 subtypes, particularly in the context of clinical signs consistent with HPAI (e.g., high mortality, edema, cyanosis), may trigger immediate reporting to veterinary authorities and implementation of stamping-out policies. Detection of H9, which typically circulates as a low pathogenicity strain, may indicate a need for enhanced biosecurity and vaccination strategies.

The multiplex assay must be periodically re-evaluated as new genetic lineages of AIV emerge. Point mutations in the HA gene, particularly at primer and probe binding sites, can lead to false-negative results. In silico analysis of newly sequenced HA genes and regular alignment of primer-probe sequences against public databases (e.g., GenBank, GISAID) are necessary to ensure ongoing assay validity. Laboratories should maintain a repository of characterized viral RNA for use as positive controls and for monitoring assay performance over time.

The multiplex assay can be integrated into a broader diagnostic algorithm that includes initial screening by a generic AIV M-gene assay. Samples positive by the M-gene assay are then subtyped using the multiplex H5/H7/H9 assay. Samples negative for H5, H7, and H9 on the multiplex panel can be further tested by sequencing or by subtype-specific assays for other HA subtypes (e.g., H1, H3). This tiered approach optimizes resource use and maintains high throughput.

The principles described here are analogous to those used for multiplex panels targeting other respiratory pathogens in livestock, such as the panel described for High-Throughput Multiplex Real-Time RT-PCR Panel for Simultaneous Detection and Subtyping of Avian Influenza Virus, Newcastle Disease Virus, and Infectious Bronchitis Virus in Poultry. The same rigorous validation framework, including assessment of analytical sensitivity, specificity, and field performance, should be applied to any new multiplex panel introduced into a diagnostic laboratory.

Conclusion

A well-designed and thoroughly validated multiplex real-time RT-PCR assay for simultaneous detection of AIV H5, H7, and H9 subtypes is a powerful tool for veterinary diagnostics and poultry disease surveillance. The assay provides rapid, specific, and sensitive identification of these three clinically and epidemiologically relevant subtypes directly from respiratory samples. The incorporation of a robust internal control ensures the reliability of negative results. Ongoing monitoring of circulating viral sequences and periodic re-validation are essential to maintain assay performance over time.

References

[1] Lung O, Beeston A, Ohene-Adjei S, et al. Electronic microarray assays for avian influenza and Newcastle disease virus. J Virol Methods. 2012. Available at: https://pubmed.ncbi.nlm.nih.gov/22796283/

[2] Kuriakose T, Hilt DA, Jackwood MW. Detection of avian influenza viruses and differentiation of H5, H7, N1, and N2 subtypes using a multiplex microsphere assay. Avian Dis. 2012. Available at: https://pubmed.ncbi.nlm.nih.gov/22545533/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.